Sr. Manager, Global Strategic Insights, HIDO, Global Rare Diseases; Boston, MA,
Listed on 2026-09-14
-
Research/Development
Market Research
About Us
Based in Parma, Italy, Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in 31 countries. More than 8,000 employees across the group are united by a singular purpose: promoting a healthier world for our people, patients, and the planet. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas.
Discover more here.
At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. This fosters a culture of reliability, transparency, and ethical behaviour at every level. As a Benefit Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact.
Diversity, inclusion, and equal opportunity are at the heart of who we are. We believe our differences make us stronger. We are a vibrant ecosystem of passionate, talented individuals united by strong values, each bringing unique perspectives that help us to continuously challenge the status quo for the better.
Chiesi Global Rare DiseasesChiesi Global Rare Diseases is a Chiesi Group’s business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare disorders, many of whom have limited or no treatments available.
This unit is based in Boston, Massachusetts, with a strong synergy with the headquarters in Parma.
Rare unit has a focus on research and product development for lysosomal storage diseases, rare hematology, ophthalmology disorders and rare immunodeficiencies. The unit is also a dedicated partner with global leaders in scientific research, patient advocacy and care. Discover more here.
Who we are looking forThis is what you will doReporting to the Lead, HIDO Global Strategic Insights, the Senior Manager, HIDO Global Strategic Insights will be responsible for leading the analysis of market trends, customer behavior and industry insights to inform strategic decision-making for brands in the HIDO Franchise. The role will be Global in scope.
The ideal candidate is capable of developing a coherent data collection strategy for providing business insights supporting successful product launches, in-line product growth, evaluation of business development opportunities and therapy area forecasts. Candidate should be able to collect and integrate insights from a variety of data sources including primary, secondary and competitive intelligence.
- Strategic Planning:
Develop and implement comprehensive strategies for the successful launch of new products, considering market trends, competitive landscape, and company goals. - Cross-Functional Collaboration:
Work closely with R&D, Marketing, Sales and other relevant departments to maximize the potential of new and existing products. - Market Research:
Design and execute qualitative and quantitative US and Global market research (vendor identification, methodology selection, questionnaire/discussion guide design, summary, presentation of results) - Financial Analysis:
Assist with evaluating the financial viability of new products - Competitive Intelligence:
Monitor and analyze competitors’ activities and market dynamics to identify opportunities and threats - Innovation:
Collaborate in the planning, development, and deployment of new data solutions and evaluate and improve existing data solutions and dashboards
- Bachelor’s degree in a life science
- 5+ years pharmaceutical brand marketing, new product planning or insights experience
- Solutions-oriented, strong analytical and presentation skills
- Creative, innovative, problem-solving approach
- Independent self-starter
- Willingness to travel approximately 25%, including some…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).